Guerzoni, S. et al. 2024. Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache. Confinia Cephalalgica. 34, 1 (May 2024). DOI:https://doi.org/10.4081/cc.2024.15760.